PM360 2019 Innovative Startup Drugviu


Kwaku Owusu, Co-Founder & CEO

Co-founders Kwaku Owusu and Melanie Igwe. (Photo by Ketan Awasthi)

Drugviu is a digital health platform expanding the dataset on health, genomic, and medication outcomes to include Asian, Black, Latino, and Native Americans. These populations are 40% of the U.S. population, but represent less than 6% of participants in clinical trials.

Drugviu has built a safe place for population of color to connect, talk about their health, and share their real-world outcomes including medication efficacy, side effects, and adherence. The company then aggregates their responses by demographics to make it easy for people to discover how medications are performing in other people like them. Along with Drugviu’s website, the company has also partnered with clinics, oncologists, and specialty pharmacies in Ghana, Nigeria, Texas, Illinois, and Hawaii to source medication outcomes across diverse populations.  Currently, the company is focused on collecting medication outcomes across cardiovascular conditions, type 2 diabetes, GI, and oncology (breast, lung, prostate, and colorectal cancers). To date, Drugviu has 32,000 medication outcomes—and its growing at 30% per week.

To improve minority representation in clinical trials, Drugviu has built a sophisticated matching algorithm that can identify and place the right patient to the right clinical trial more efficiently. The company sees other applications for its technology including combining its large dataset of therapeutic outcomes with genomic data of underserved populations to help with research and drug design.


You May Also Like

PM360 2020 Innovative Company Bionical Solutions

Bionical Solutions Mike Viscel, President Bionical Solutions has been providing engagement platforms to ...

ELITE 2020 Leader of the Future Kavita Patel of Genentech/Hoffmann-La Roche

Kavita Patel LifeCycle Leader Genentech/Hoffmann-La Roche Leading Significant Change Management When Kavita Patel joined ...

PM360 2019 Trailblazer Awards Rare Diseases Brand Champion Julie Baker

Julie Baker, Senior Director, Epidiolex Marketing, Greenwich Biosciences For patients and families affected by ...